Elongin BC complex negatively regulates AXL and marks a differentiated phenotype in melanoma
Daniel S. Peeper(Oncode Institute), Thomas Kuilman(AstraZeneca (Netherlands))
Cited by 0
Related Papers
BRAFE600-associated senescence-like cell cycle arrest of human naevi
|Nature|2005|2.1k
The essence of senescence: Figure 1.
|Genes & Development|2010|2k
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
|Nature Communications|2014|633
Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts
|EMBO Molecular Medicine|2015|143